Re: Additional Reports of Exempt Distribution

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Additional Reports of Exempt Distribution

in response to

Additional Reports of Exempt Distribution

KOO-KOO2

posted on Jul 22, 2023 07:01AM

Another Report of Exempt Distribution:

Dated:2023-07-13 out of USA

166,667 common shares @ $0.99 = $164,100.00 CAN

2 warrants per common share @ $0.99 expire 2028-07-13

Koo

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply